Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 57 (13%) | |
Anticipated shortage: | 14 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 366 (82%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (15%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LEVETIRACETAM | 250MG | TABLET | Resolved | 2024-01-30 | 2024-03-02 | 217793 |
LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2020-10-20 | 2020-11-19 | 126743 |
LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-08-02 | 2020-02-27 | 17964 |
LORAZEPAM | 2.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135879 |
LORAZEPAM | 1.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135885 |
LOSARTAN | 25MG | TABLET | Resolved | 2018-11-21 | 2019-07-26 | 67318 |
LOSARTAN | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67324 |
LOSARTAN | 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-26 | 67327 |
LOSARTAN | 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82935 |
LOSARTAN | 50MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82938 |
LOSARTAN | 25MG | TABLET | Resolved | 2019-07-25 | 2021-05-06 | 89940 |
LOSARTAN | 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145528 |
LOSARTAN | 25MG | TABLET | Actual shortage | 2021-09-13 | 2021-09-14 | 145531 |
LOSARTAN | 50MG | TABLET | Actual shortage | 2021-09-13 | 2024-04-03 | 145534 |
LOSARTAN | 100MG | TABLET | Actual shortage | 2021-09-20 | 2024-04-23 | 145888 |
LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67312 |
LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67315 |
LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67321 |
LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82941 |
LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145537 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |